Bagonza A, Gibson L, Kabiri L, Bezalel C, Narahari S, Franks P
PLoS Negl Trop Dis. 2025; 19(1):e0012747.
PMID: 39787113
PMC: 11717300.
DOI: 10.1371/journal.pntd.0012747.
Parvin R, Masum M, Ferdous J, Mahdeen A, Khan M
PLoS One. 2024; 19(9):e0310398.
PMID: 39298468
PMC: 11412548.
DOI: 10.1371/journal.pone.0310398.
Amanyi-Enegela J, Badaki J, Pali M, Okunade F, Kumbur J, Omoi S
Int Health. 2024; 16(Supplement_1):i22-i29.
PMID: 38547349
PMC: 10977946.
DOI: 10.1093/inthealth/ihae002.
Barrett C, Chiphwanya J, Mkwanda S, Matipula D, Ndhlovu P, Chaponda L
PLoS Negl Trop Dis. 2024; 18(3):e0012056.
PMID: 38527064
PMC: 11018277.
DOI: 10.1371/journal.pntd.0012056.
Aarthy M, Pandiyan G, Paramasivan R, Kumar A, Gupta B
Sci Rep. 2024; 14(1):1970.
PMID: 38263422
PMC: 10806236.
DOI: 10.1038/s41598-024-52457-x.
Molecular detection of and its endosymbionts in dogs from Myanmar.
Bawm S, Khaing Y, Chel H, Hmoon M, Win S, Bo M
Curr Res Parasitol Vector Borne Dis. 2023; 4:100148.
PMID: 38021190
PMC: 10665652.
DOI: 10.1016/j.crpvbd.2023.100148.
Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis.
Chhonker Y, Bjerum C, Bala V, Ouattara A, Koudou B, Gabo T
PLoS Negl Trop Dis. 2023; 17(8):e0011567.
PMID: 37616301
PMC: 10482275.
DOI: 10.1371/journal.pntd.0011567.
Programmed cell death pathways as targets for developing antifilarial drugs: Lessons from the recent findings.
Chandra Das N, Chakraborty P, Nandy S, Dey A, Malik T, Mukherjee S
J Cell Mol Med. 2023; 27(19):2819-2840.
PMID: 37605891
PMC: 10538269.
DOI: 10.1111/jcmm.17913.
Evaluating the availability and quality of services for lymphatic filariasis morbidity in Ghana.
Edmiston M, Atinbire S, Mensah E, Mensah E, Alomatu B, Asemanyi Mensah K
PLoS Negl Trop Dis. 2023; 17(6):e0010805.
PMID: 37307289
PMC: 10289431.
DOI: 10.1371/journal.pntd.0010805.
Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis.
Alshehri A, Chhonker Y, Bala V, Edi C, Bjerum C, Koudou B
PLoS Negl Trop Dis. 2023; 17(6):e0011319.
PMID: 37262040
PMC: 10234547.
DOI: 10.1371/journal.pntd.0011319.
Coverage and compliance of mass drug administration in lymphatic filariasis amidst the COVID-19 pandemic: A community based epidemiological study.
Chakraborty S, Bhattacharya T
Trop Parasitol. 2023; 12(2):105-112.
PMID: 36643986
PMC: 9832500.
DOI: 10.4103/tp.tp_32_21.
Assessment of the Impact of Morbidity Management and Disability Prevention for Lymphatic Filariasis on the Disease Burden in Villupuram District of Tamil Nadu, India.
Mathiarasan L, Das L, Krishnakumari A
Indian J Community Med. 2022; 46(4):657-661.
PMID: 35068729
PMC: 8729271.
DOI: 10.4103/ijcm.IJCM_12_21.
Highlighting the Relevance of CD8 T Cells in Filarial Infections.
Kwarteng A, Asiedu E, Koranteng K, Opoku Asiedu S
Front Immunol. 2021; 12:714052.
PMID: 34603287
PMC: 8481813.
DOI: 10.3389/fimmu.2021.714052.
Assessing the Filariasis Causing Parasites in Adult Mosquitoes and the Vector Mosquito Larval Breeding in Selected Medical Officer of Health Areas in Gampaha District, Sri Lanka.
Pilagolla S, Amarasinghe L
J Trop Med. 2021; 2021:6643226.
PMID: 33927771
PMC: 8053054.
DOI: 10.1155/2021/6643226.
Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study.
Khaemba C, Barry A, Omondi W, Bota K, Matendechero S, Wandera C
Pharmaceuticals (Basel). 2021; 14(3).
PMID: 33804133
PMC: 8001901.
DOI: 10.3390/ph14030264.
Coexistent malaria and filaria among the febrile patients attending for malaria diagnosis: A clinic-based study.
Acharya A, Rakshit A, Halder S, Chatterjee M, Chakrabarti S, Saha P
Trop Parasitol. 2021; 10(2):109-113.
PMID: 33747877
PMC: 7951078.
DOI: 10.4103/tp.TP_93_20.
Community-directed distributors-The "foot soldiers" in the fight to control and eliminate neglected tropical diseases.
Amazigo U, Leak S, Zoure H, Okoronkwo C, Diop Ly M, Isiyaku S
PLoS Negl Trop Dis. 2021; 15(3):e0009088.
PMID: 33661903
PMC: 7932156.
DOI: 10.1371/journal.pntd.0009088.
Drugs that target early stages of Onchocerca volvulus: A revisited means to facilitate the elimination goals for onchocerciasis.
Jawahar S, Tricoche N, Bulman C, Sakanari J, Lustigman S
PLoS Negl Trop Dis. 2021; 15(2):e0009064.
PMID: 33600426
PMC: 7891776.
DOI: 10.1371/journal.pntd.0009064.
High concentrations of membrane-fed ivermectin are required for substantial lethal and sublethal impacts on Aedes aegypti.
Hadlett M, Nagi S, Sarkar M, Paine M, Weetman D
Parasit Vectors. 2021; 14(1):9.
PMID: 33407825
PMC: 7789309.
DOI: 10.1186/s13071-020-04512-5.
Progress in the elimination of lymphatic filariasis in the Western Pacific Region: successes and challenges.
Yajima A, Ichimori K
Int Health. 2020; 13(Suppl 1):S10-S16.
PMID: 33349886
PMC: 7753160.
DOI: 10.1093/inthealth/ihaa087.